CA
NZ
UK
AU
IND
US
…
Talkspace, Inc., together with its subsidiaries, operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States. The company provides psychotherapy and psychiatry services to treat various mental health conditions, such as depression, anxiety, trauma, and other fields of human challenges by operating an online platform for one-on-one therapy delivered through messaging, audio, and video channels. It serves health insurance plans and employee assistance programs, direct-to-enterprise customers, and individual subscribers. The company was formerly known as Groop Internet Platform Inc. and changed its name to Talkspace, Inc. in June 2021. The company was founded in 2012 and is headquartered in New York, New York. As of August 17, 2026, Talkspace, Inc. operates as a subsidiary of Universal Health Services, Inc.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Talkspace operates a digital mental-health platform connecting users with licensed therapists via messaging and video for consumers and employer/payer clients. Long-term growth may be driven by rising demand for mental-health services, telehealth adoption and expansion of employer and payer contracts, which could support scalable recurring revenue.
Key risks include intense competition, challenges achieving sustained profitability and scale, reimbursement and regulatory uncertainty, clinician supply constraints and data-privacy obligations.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 8.37M | 1.24M | -18.96M | -79.42M | -62.70M |
| Net income | 7.79M | 1.15M | -19.18M | -79.67M | -62.74M |
| Selling general administrative | 21.77M | 22.63M | 21.32M | 36.27M | 34.77M |
| Selling and marketing expenses | 53.80M | 50.65M | 52.54M | 72.84M | 100.64M |
| Gross profit | 98.35M | 85.84M | 74.38M | 60.34M | 66.77M |
| Reconciled depreciation | 2.88M | 0.86M | 1.26M | 1.36M | 1.97M |
| Ebit | 8.37M | 1.24M | -18.96M | -77.02M | -93.92M |
| Ebitda | 11.24M | 2.10M | -17.77M | -69.53M | -91.95M |
| Depreciation and amortization | 2.88M | 0.86M | 1.20M | 7.49M | 1.97M |
| Operating income | 3.15M | -4.50M | -23.21M | -77.02M | -93.92M |
| Other operating expenses | 225.72M | 192.09M | 173.25M | 196.59M | 207.59M |
| Interest expense | - | - | - | 3.74M | 31.23M |
| Tax provision | 0.57M | 0.09M | 0.29M | 0.25M | 0.05M |
| Interest income | - | - | - | 3.74M | - |
| Net interest income | 5.21M | 5.74M | 5.77M | 3.74M | 31.23M |
| Income tax expense | 0.57M | 0.09M | 0.22M | 0.25M | 0.05M |
| Total revenue | 228.87M | 187.59M | 150.04M | 119.57M | 113.67M |
| Total operating expenses | 95.20M | 90.33M | 97.59M | 137.36M | 160.69M |
| Cost of revenue | 130.52M | 101.76M | 75.67M | 59.23M | 46.90M |
| Total other income expense net | 5.21M | 5.74M | 4.25M | -2.39M | 31.23M |
| Net income from continuing ops | 7.79M | 1.15M | -36.18M | -79.67M | -62.74M |
| Net income applicable to common shares | - | - | - | -79.67M | -62.74M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 134.86M | 138.68M | 142.22M | 156.25M | 223.61M |
| Intangible assets | 3.87M | 1.34M | 1.79M | 2.53M | 3.44M |
| Other current assets | 2.42M | 2.73M | 5.72M | 4.37M | 9.56M |
| Total liab | 17.85M | 21.28M | 23.57M | 28.72M | 31.33M |
| Total stockholder equity | 117.02M | 117.39M | 118.65M | 127.54M | 192.27M |
| Other current liab | 6.67M | 8.03M | 12.47M | 16.50M | 2.59M |
| Common stock | 0.02M | 0.02M | 0.02M | 0.02M | 0.01M |
| Capital stock | 0.02M | 0.02M | 0.02M | 0.02M | 0.01M |
| Retained earnings | -261.44M | -269.24M | -270.38M | -251.20M | -171.53M |
| Other liab | - | - | - | 1.20M | 4.16M |
| Good will | 3.32M | 0.00M | - | 0.00M | 6.13M |
| Other assets | - | - | 0.00M | 0.09M | 0.08M |
| Cash | 37.35M | 76.69M | 123.91M | 138.54M | 198.26M |
| Total current liabilities | 17.40M | 19.02M | 21.65M | 27.32M | 27.18M |
| Current deferred revenue | 2.22M | 3.28M | 3.07M | 4.36M | 7.19M |
| Net debt | -37.35M | -76.69M | -123.91M | -138.54M | -198.26M |
| Short term debt | - | - | - | - | 9.97M |
| Other stockholder equity | 378.38M | 386.61M | 389.01M | 378.72M | 363.79M |
| Property plant equipment | - | - | - | 0.68M | 0.62M |
| Total current assets | 111.06M | 130.18M | 139.80M | 152.56M | 213.33M |
| Net tangible assets | - | - | - | 125.01M | 182.70M |
| Short term investments | 55.23M | 41.12M | - | - | - |
| Net receivables | 16.06M | 9.64M | 10.17M | 9.64M | 5.51M |
| Accounts payable | 8.50M | 7.71M | 6.11M | 6.46M | 7.43M |
| Accumulated other comprehensive income | 0.06M | 0.00M | - | - | -223.61M |
| Common stock total equity | - | - | - | 0.02M | 0.01M |
| Retained earnings total equity | - | - | - | -251.20M | -171.53M |
| Non currrent assets other | 0.82M | 0.90M | 0.32M | 0.49M | 0.08M |
| Non current assets total | 23.80M | 8.49M | 2.42M | 3.70M | 10.28M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -13.26M | -46.73M | -0.07M | -0.32M | -0.66M |
| Change to liabilities | - | - | - | 4.00M | 2.52M |
| Total cashflows from investing activities | -28.88M | -46.31M | -0.14M | -0.32M | -0.66M |
| Net borrowings | - | - | 0.00M | - | - |
| Total cash from financing activities | -19.00M | -12.19M | 1.90M | 1.68M | 251.38M |
| Change to operating activities | - | - | - | 10.04M | -3.66M |
| Net income | -5.21M | 1.15M | -19.18M | -79.67M | -62.74M |
| Change in cash | -39.34M | -47.22M | -14.64M | -59.71M | 185.01M |
| Begin period cash flow | 76.69M | 123.91M | 138.54M | 198.26M | 13.25M |
| End period cash flow | 37.35M | 76.69M | 123.91M | 138.54M | 198.26M |
| Total cash from operating activities | 8.53M | 11.29M | -16.39M | -61.08M | -65.71M |
| Issuance of capital stock | - | - | - | - | 0.00M |
| Depreciation | 2.88M | 0.86M | 1.20M | 1.36M | 1.97M |
| Other cashflows from investing activities | -0.07M | -0.17M | 0.01M | 0.03M | - |
| Change to inventory | - | - | - | - | -3.66M |
| Change to account receivables | -6.42M | 0.53M | -0.53M | -4.13M | 0.40M |
| Sale purchase of stock | -17.20M | -11.00M | 0.00M | 3.18M | 2.05M |
| Other cashflows from financing activities | -2.71M | -3.19M | -0.81M | -1.50M | 257.38M |
| Change to netincome | - | - | - | 18.25M | -4.38M |
| Capital expenditures | 10.64M | 5.44M | 0.15M | 0.35M | 0.66M |
| Change receivables | - | - | - | -4.13M | 0.40M |
| Cash flows other operating | - | - | - | -0.88M | -37.82M |
| Cash and cash equivalents changes | - | - | - | -59.71M | 185.01M |
| Change in working capital | -8.23M | 0.90M | -7.55M | 2.12M | -0.74M |
| Stock based compensation | 8.45M | 9.17M | 8.39M | 12.12M | 27.41M |
| Other non cash items | 10.66M | -0.79M | 0.75M | 3.00M | 0.17M |
| Free cash flow | -2.11M | 5.84M | -16.54M | -61.43M | -66.37M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems Inc Class A |
-3.11 1.01% |
303.89 | 43.49 | 29.59 | 12.48 | 5.79 | 10.39 | 33.41 |
| PMCUF Pro Medicus Limited |
- -% |
132.14 | 64.90 | 90.91 | 49.11 | 38.05 | 65.12 | 83.47 |
| TEM Tempus AI, Inc. Class A Common Stock |
-0.75 0.96% |
77.73 | - | - | 8.68 | 25.39 | 8.33 | - |
| MTHRY M3 Inc |
-0.05 0.87% |
5.70 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Talkspace, Inc., together with its subsidiaries, operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States. The company provides psychotherapy and psychiatry services to treat various mental health conditions, such as depression, anxiety, trauma, and other fields of human challenges by operating an online platform for one-on-one therapy delivered through messaging, audio, and video channels. It serves health insurance plans and employee assistance programs, direct-to-enterprise customers, and individual subscribers. The company was formerly known as Groop Internet Platform Inc. and changed its name to Talkspace, Inc. in June 2021. The company was founded in 2012 and is headquartered in New York, New York. As of August 17, 2026, Talkspace, Inc. operates as a subsidiary of Universal Health Services, Inc.
| Name | Title | Year Born |
|---|---|---|
| Ms. Jennifer Fulk | Chief Financial Officer | 1977 |
| Mr. Gil Margolin | Chief Technology Officer | 1978 |
| Mr. John Charles Reilly | Gen. Counsel & Corp. Sec. | 1966 |
| Dr. Jon R. Cohen M.D. | CEO & Director | 1955 |
| Mr. Michael Lovell | Sr. Director of Investor Relations | NA |
| Ms. Katelyn Watson | Chief Marketing Officer | NA |
| Dr. Varun Choudhary DFAPA, M.A., M.D. | Chief Medical Officer | NA |
| Ms. Michaela Yule | Chief Strategy Officer | NA |
| Ms. Erin Boyd | Chief Growth Officer of Enterprise | 1969 |
| Mr. Richie Nguyen | Sr. VP of Network & Provider Operations | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-0.39%
Communication Services
+0.40%
Consumer Cyclical
-0.20%
Consumer Defensive
-0.56%
Energy
-0.45%
Financial Services
-0.09%
Financials
+0.11%
Healthcare
+0.40%
Industrials
+0.34%
Real Estate
-0.14%
Technology
+0.88%
Utilities
+0.11%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...